Synergy Pharmaceuticals - Gastrointestinal Disorders and Diseases

11.12.09	Synergy Pharmaceuticals Raises $8.6 Million in Common Stock Financing
10.08.09	Synergy Pharmaceuticals Announces Appointment of Dr. Alan F. Joslyn to Board of Directors
10.05.09	Synergy Pharmaceuticals to Present at the 17th Annual BioPartnering Europe Conference in London, UK
07.07.09	Synergy Pharmaceuticals Raises $7.09 Million in Common Stock Financing
05.26.09	Synergy Pharmaceuticals to Present Phase I Volunteer Study on SP-304 Investigational Drug to Treat GI Disorders at Upcoming Conference
12.09.08	Synergy Pharmaceuticals Successfully Completes Phase 1 Trials in Volunteers
08.28.08	Synergy Pharmaceuticals Announces Appointment of Dr. Mel Spigelman to Board of Directors
08.11.08	Synergy Pharmaceuticals Inc. Affects Name Change and Forward Stock Split